NDA Group - an SSI Strategy Company Email Format
Pharmaceutical ManufacturingStockholm, Sweden51-200 Employees
NDA Group is a regulatory affairs and drug development consultancy within the SSI Strategy group, positioned as its regulatory powerhouse. For more than 25 years, NDA Group has leveraged its experience and global network to help clients optimize regulatory strategies, expedite filings, and secure successful approvals in key markets worldwide. By integrating with SSI Strategy’s capabilities in clinical development, medical affairs, and commercial planning, NDA Group provides a holistic solution aimed at maximizing asset value and supporting timely patient access to therapies. The company is based in Sweden, at 2 Johanneslundsvägen, Upplands Väsby, Stockholm 194 61, and employs 51–200 people. In August 2023, SSI Strategy announced the acquisition of NDA Group AB.